Cargando…

Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection

Few studies have been conducted on the relationship between metabolic syndrome (MetS) and cervical human papillomavirus (HPV) incidence and persistent infection. We performed a prospective cohort study including 8598 female employees in Hunan, China. First, the subjects were stratified into HPV-nega...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xin, Zhao, Qun, Yang, Pingting, Li, Ying, Yuan, Hong, Wu, Liuxin, Chen, Zhiheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782868/
https://www.ncbi.nlm.nih.gov/pubmed/26945384
http://dx.doi.org/10.1097/MD.0000000000002905
_version_ 1782420028603236352
author Huang, Xin
Zhao, Qun
Yang, Pingting
Li, Ying
Yuan, Hong
Wu, Liuxin
Chen, Zhiheng
author_facet Huang, Xin
Zhao, Qun
Yang, Pingting
Li, Ying
Yuan, Hong
Wu, Liuxin
Chen, Zhiheng
author_sort Huang, Xin
collection PubMed
description Few studies have been conducted on the relationship between metabolic syndrome (MetS) and cervical human papillomavirus (HPV) incidence and persistent infection. We performed a prospective cohort study including 8598 female employees in Hunan, China. First, the subjects were stratified into HPV-negative (N = 7282) and HPV-positive (N = 1316) subgroups, according to the results of an HPV DNA test at baseline. Second, comparisons of the risks of HPV incident and persistent infection between MetS-positive (exposed) and MetS-negative (unexposed) groups were conducted among the HPV-negative and -positive subgroups, respectively. There were 976 (11.39%) subjects diagnosed with MetS and 1316 subjects diagnosed with HPV infection at baseline. The 12-month cumulative incidence of any type of HPV and high-risk type HPV were 7.28% (530/7282) and 6.26% (456/7282), respectively. Obesity was a modifier of the association between MetS and HPV incident infection. As long as obesity presented, MetS and hypertriglyceridemia were significantly associated with an increased risk of HPV incident infection (any-type or high-risk type) (adjusted risk ratios (RR) were 2.88 (95% confidence interval (CI): 1.16, 7.19) and 3.29 (95% CI: 1.47, 7.38), respectively). Among those infected with HPV at baseline, the 12-month type-specific persistence rates were 51.67% and 53.38% for any-type and high-risk type HPV, respectively. No interaction was found between obesity and MetS with regard to the risk of HPV persistence. After adjustment for confounding factors, MetS was still associated with increased risk of any-type HPV persistence (RR(adj) = 1.21, 95% CI: 1.05, 1.41) and high-risk type HPV persistence (RR(adj) = 1.25, 95% CI: 1.09, 1.46). No single metabolic component was associated with the risk of HPV persistence. The prevalence of MetS was 11.39% among the Hunan female occupational population. MetS was associated with an increased risk of persistent cervical HPV infection and also with an increased risk of HPV incident infection when obesity presented as well.
format Online
Article
Text
id pubmed-4782868
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-47828682016-03-24 Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection Huang, Xin Zhao, Qun Yang, Pingting Li, Ying Yuan, Hong Wu, Liuxin Chen, Zhiheng Medicine (Baltimore) 5700 Few studies have been conducted on the relationship between metabolic syndrome (MetS) and cervical human papillomavirus (HPV) incidence and persistent infection. We performed a prospective cohort study including 8598 female employees in Hunan, China. First, the subjects were stratified into HPV-negative (N = 7282) and HPV-positive (N = 1316) subgroups, according to the results of an HPV DNA test at baseline. Second, comparisons of the risks of HPV incident and persistent infection between MetS-positive (exposed) and MetS-negative (unexposed) groups were conducted among the HPV-negative and -positive subgroups, respectively. There were 976 (11.39%) subjects diagnosed with MetS and 1316 subjects diagnosed with HPV infection at baseline. The 12-month cumulative incidence of any type of HPV and high-risk type HPV were 7.28% (530/7282) and 6.26% (456/7282), respectively. Obesity was a modifier of the association between MetS and HPV incident infection. As long as obesity presented, MetS and hypertriglyceridemia were significantly associated with an increased risk of HPV incident infection (any-type or high-risk type) (adjusted risk ratios (RR) were 2.88 (95% confidence interval (CI): 1.16, 7.19) and 3.29 (95% CI: 1.47, 7.38), respectively). Among those infected with HPV at baseline, the 12-month type-specific persistence rates were 51.67% and 53.38% for any-type and high-risk type HPV, respectively. No interaction was found between obesity and MetS with regard to the risk of HPV persistence. After adjustment for confounding factors, MetS was still associated with increased risk of any-type HPV persistence (RR(adj) = 1.21, 95% CI: 1.05, 1.41) and high-risk type HPV persistence (RR(adj) = 1.25, 95% CI: 1.09, 1.46). No single metabolic component was associated with the risk of HPV persistence. The prevalence of MetS was 11.39% among the Hunan female occupational population. MetS was associated with an increased risk of persistent cervical HPV infection and also with an increased risk of HPV incident infection when obesity presented as well. Wolters Kluwer Health 2016-03-07 /pmc/articles/PMC4782868/ /pubmed/26945384 http://dx.doi.org/10.1097/MD.0000000000002905 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5700
Huang, Xin
Zhao, Qun
Yang, Pingting
Li, Ying
Yuan, Hong
Wu, Liuxin
Chen, Zhiheng
Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection
title Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection
title_full Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection
title_fullStr Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection
title_full_unstemmed Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection
title_short Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection
title_sort metabolic syndrome and risk of cervical human papillomavirus incident and persistent infection
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782868/
https://www.ncbi.nlm.nih.gov/pubmed/26945384
http://dx.doi.org/10.1097/MD.0000000000002905
work_keys_str_mv AT huangxin metabolicsyndromeandriskofcervicalhumanpapillomavirusincidentandpersistentinfection
AT zhaoqun metabolicsyndromeandriskofcervicalhumanpapillomavirusincidentandpersistentinfection
AT yangpingting metabolicsyndromeandriskofcervicalhumanpapillomavirusincidentandpersistentinfection
AT liying metabolicsyndromeandriskofcervicalhumanpapillomavirusincidentandpersistentinfection
AT yuanhong metabolicsyndromeandriskofcervicalhumanpapillomavirusincidentandpersistentinfection
AT wuliuxin metabolicsyndromeandriskofcervicalhumanpapillomavirusincidentandpersistentinfection
AT chenzhiheng metabolicsyndromeandriskofcervicalhumanpapillomavirusincidentandpersistentinfection